View in EDS HTML Full Text PDF Full Text

Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer.

Saved in:
Bibliographic Details
Title: Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer.
Authors: Tiruye, Tenaw (AUTHOR), Hiwase, Mrunal (AUTHOR), Charlick, Megan (AUTHOR), O'Callaghan, Michael (AUTHOR), Khalid, Ashna (AUTHOR), Li, Ming (AUTHOR), FitzGerald, Liesel M. (AUTHOR), Caughey, Gillian E. (AUTHOR), Ettridge, Kerry (AUTHOR), Roder, David (AUTHOR), Beckmann, Kerri (AUTHOR)
Source: Psycho-Oncology. Jul2024, Vol. 33 Issue 7, p1-11. 11p.
Subjects: Medical care use, Mental health screening, Prostate cancer, Prostate cancer patients, Mental health services, Cancer diagnosis, Psychiatric drugs
Geographic Terms: South Australia
Abstract: Objective: Prostate cancer can significantly impact mental wellbeing, creating uncertainty and morbidity. This study described patterns of psychotropic medication and mental health service use, as a proxy measure for mental health problems, 5 years before and 5 years after prostate cancer diagnosis. Methods: Population‐based registry data were linked with Pharmaceutical Benefits Scheme and Medicare Benefits Schedule data for all prostate cancer patients diagnosed in South Australia between 2012 and 2020 (n = 13,693). We estimated the proportion and rates of psychotropic medication and mental health service use before and after diagnosis. Multivariable adjusted interrupted time series analyses (ITSA) were conducted to uncover temporal patterns. Results: Fifteen percent of men commenced psychotropic medications and 6.4% sought out mental health services for the first time after diagnosis. Psychotropic medication use rose from 34.5% 5 years before to 40.3% 5 years after diagnosis, including an increase in use of antidepressants (from 20.7% to 26.0%) and anxiolytics (from 11.3% to 12.8%). Mental health service use increased from 10.2% to 12.1%, with the increase mostly being general practice mental health visits (from 7.8% to 10.6%). Multivariable ITSA indicated a significant rise in medication and service utilisation immediately before and in the first 2 years following prostate cancer diagnosis. Conclusion: There is a clear increase in psychotropic medication use and mental health service use around the time of prostate cancer diagnosis. Mental health outcomes of men with prostate cancer may be improved with early mental health screening, particularly during the diagnosis process, to enable early intervention. [ABSTRACT FROM AUTHOR]
Copyright of Psycho-Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 178649457
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Tiruye%2C+Tenaw%22">Tiruye, Tenaw</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hiwase%2C+Mrunal%22">Hiwase, Mrunal</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Charlick%2C+Megan%22">Charlick, Megan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22O'Callaghan%2C+Michael%22">O'Callaghan, Michael</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Khalid%2C+Ashna%22">Khalid, Ashna</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Ming%22">Li, Ming</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22FitzGerald%2C+Liesel+M%2E%22">FitzGerald, Liesel M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Caughey%2C+Gillian+E%2E%22">Caughey, Gillian E.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ettridge%2C+Kerry%22">Ettridge, Kerry</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Roder%2C+David%22">Roder, David</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beckmann%2C+Kerri%22">Beckmann, Kerri</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Psycho-Oncology%22">Psycho-Oncology</searchLink>. Jul2024, Vol. 33 Issue 7, p1-11. 11p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Medical+care+use%22">Medical care use</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+health+screening%22">Mental health screening</searchLink><br /><searchLink fieldCode="DE" term="%22Prostate+cancer%22">Prostate cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Prostate+cancer+patients%22">Prostate cancer patients</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+health+services%22">Mental health services</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+diagnosis%22">Cancer diagnosis</searchLink><br /><searchLink fieldCode="DE" term="%22Psychiatric+drugs%22">Psychiatric drugs</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22South+Australia%22">South Australia</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective: Prostate cancer can significantly impact mental wellbeing, creating uncertainty and morbidity. This study described patterns of psychotropic medication and mental health service use, as a proxy measure for mental health problems, 5 years before and 5 years after prostate cancer diagnosis. Methods: Population‐based registry data were linked with Pharmaceutical Benefits Scheme and Medicare Benefits Schedule data for all prostate cancer patients diagnosed in South Australia between 2012 and 2020 (n = 13,693). We estimated the proportion and rates of psychotropic medication and mental health service use before and after diagnosis. Multivariable adjusted interrupted time series analyses (ITSA) were conducted to uncover temporal patterns. Results: Fifteen percent of men commenced psychotropic medications and 6.4% sought out mental health services for the first time after diagnosis. Psychotropic medication use rose from 34.5% 5 years before to 40.3% 5 years after diagnosis, including an increase in use of antidepressants (from 20.7% to 26.0%) and anxiolytics (from 11.3% to 12.8%). Mental health service use increased from 10.2% to 12.1%, with the increase mostly being general practice mental health visits (from 7.8% to 10.6%). Multivariable ITSA indicated a significant rise in medication and service utilisation immediately before and in the first 2 years following prostate cancer diagnosis. Conclusion: There is a clear increase in psychotropic medication use and mental health service use around the time of prostate cancer diagnosis. Mental health outcomes of men with prostate cancer may be improved with early mental health screening, particularly during the diagnosis process, to enable early intervention. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Psycho-Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=178649457
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/pon.6369
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 1
    Subjects:
      – SubjectFull: Medical care use
        Type: general
      – SubjectFull: Mental health screening
        Type: general
      – SubjectFull: Prostate cancer
        Type: general
      – SubjectFull: Prostate cancer patients
        Type: general
      – SubjectFull: Mental health services
        Type: general
      – SubjectFull: Cancer diagnosis
        Type: general
      – SubjectFull: Psychiatric drugs
        Type: general
      – SubjectFull: South Australia
        Type: general
    Titles:
      – TitleFull: Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tiruye, Tenaw
      – PersonEntity:
          Name:
            NameFull: Hiwase, Mrunal
      – PersonEntity:
          Name:
            NameFull: Charlick, Megan
      – PersonEntity:
          Name:
            NameFull: O'Callaghan, Michael
      – PersonEntity:
          Name:
            NameFull: Khalid, Ashna
      – PersonEntity:
          Name:
            NameFull: Li, Ming
      – PersonEntity:
          Name:
            NameFull: FitzGerald, Liesel M.
      – PersonEntity:
          Name:
            NameFull: Caughey, Gillian E.
      – PersonEntity:
          Name:
            NameFull: Ettridge, Kerry
      – PersonEntity:
          Name:
            NameFull: Roder, David
      – PersonEntity:
          Name:
            NameFull: Beckmann, Kerri
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 10579249
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Psycho-Oncology
              Type: main
ResultId 1